Clinical trial
DaBlaCa 23 - The European Collaborative Study on Upper Urinary Tract Urothelial Carcinoma
NCT07077447 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DaBlaCa 23 - The European Collaborative Study on Upper Urinary Tract Urothelial Carcinoma
- Lead sponsor
- Zealand University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 26, 2025
- Completion date
- June 30, 2040
- Enrollment
- 2,500 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
upper urinary tract urothelial carcinoma